🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to estimate the annualized relapse ra...
Status
Terminated
Location
Research Site
Start Date
2015-05
Trial ID
NCT02323269
Treatments Being Tested
The primary objective of the study is to evaluate the safety and tolerabili...
Status
Completed
Location
Research Site
Start Date
2010-06
Trial ID
NCT01156311
Treatments Being Tested
To determine if treatment with BG00012 can decrease the number of MS relaps...
Status
Completed
Location
Research Site
Start Date
2007-06
Trial ID
NCT00451451
Treatments Being Tested
The incidence of autoimmune conditions is at least 2-3 times higher in Mult...
Status
Completed
Location
USC MS Comprehensive Care Center & Research Group
Start Date
2011-09
Trial ID
NCT01456416
This study will investigate the efficacy, safety and tolerability of a new ...
Status
Terminated
Location
Teva Investigational Site 10192
Start Date
2012-03
Trial ID
NCT01578785
Treatments Being Tested
The purpose of this study is to compare pain associated with injections and...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00947752
Treatments Being Tested
The purpose of this study is to determine if natalizumab in combination wit...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00097760
Treatments Being Tested
Teva is developing 40 mg/ml Glatiramer Acetate (GA) Injection , administere...
Status
Completed
Location
Teva Benelux
Start Date
2006-07-27
Trial ID
NCT00326625
Treatments Being Tested
Assess the anti-inflammatory effects of short-term Copaxone therapy on pati...
Status
Completed
Location
Hadassah Ein Kerem medical center-hospital ,Cardiology Department
Start Date
2021-01-04
Trial ID
NCT06003972
Treatments Being Tested
The primary aim of this open-label pilot trial is to estimate the treatment...
Status
Terminated
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01073813
Treatments Being Tested